Begrundelsen for indbringelsen af sagen var betænkeligheder over utilstrækkeligheden af de kliniske data, der var fremlagt for lægemidlets virkning.
The grounds for the referral were concerns over the insufficiency of the clinical data submitted to establish the efficacy of the product.